World Health Organization, 2018. Immunization, Vaccines and Biologicals-Measles. WHO. Available at: http://www.who.int/immunization/diseases/measles/en/Downloaded. Accessed August 17, 2018.
Gurnani V, Haldar P, Aggarwal MK, Das MK, Chauhan A, Murray J, Arora NK, Jhalani M, Sudan P, 2018. Improving vaccination coverage in India: lessons from Intensified Mission Indradhanush, a cross-sectoral systems strengthening strategy. BMJ 363: k4782.
National Operational Guidelines, 2017. Measles-Rubella Vaccine Operational Guidelines, 2nd edition. New Delhi, India: Ministry of Health and Family Welfare, Government of India. Available at: https://mohfw.gov.in/sites/default/files/Measles%20rubella%20vaccine%20operational%20guidelines.pdf. Accessed February 14, 2019.
Fisher DL, Defres S, Solomon T, 2015. Measles-induced encephalitis. QJM 108: 177ā182.
Buchanan R, Bonthius DJ, 2012. Measles virus and associated central nervous system sequelae. Semin Pediatr Neurol 19: 107ā114.
Baldolli A, DargĆØre S, Cardineau E, Vabret A, Dina J, de La BlanchardiĆØre A, Verdon R, 2016. Measles inclusion-body encephalitis (MIBE) in a immunocompromised patient. J ClinVirol 81: 43ā46.
Griffin DE, 2014. Measles virus and the nervous system. Handb Clin Neurol 123: 577ā590.
Bien CG, Elger CE, 2008. Epilepsia partialis continua: semiology and differential diagnoses. Epileptic Disord 10: 3ā7.
Pandian JD, Thomas SV, Santoshkumar B, Radhakrishnan K, Sarma PS, Joseph S, Kesavadas C, 2002. Epilepsia partialis continuaāa clinical and electroencephalography study. Seizure 11: 437ā441.
MameniÅ”kienÄ R, Wolf P, 2017. Epilepsia partialis continua: a review. Seizure 44: 74ā80.
Takahashi Y et al. 2003. Kondo N Autoantibodies to NMDA receptor in patients with chronic forms of epilepsia partialis continua. Neurology 61: 891ā896.
Malhotra HS, Garg RK, Naphade P, 2012. Cluster of partial motor seizures heralding the onset of hemimyoclonic subacute sclerosing panencephalitis. Mov Disord 27: 958ā959.
Garg RK, Malhotra HS, Rizvi I, Kumar N, Jain A, 2017. An unusual case of acute encephalitic syndrome: is it acute measles encephalitis or subacute sclerosing panencephalitis? Neurol India 65: 1333ā1344.
Komur M, Arslankoylu AE, Okuyaz C, Kuyucu N, 2012. Atypical clinical course subacute sclerosing panencephalitis presenting as acute encephalitis. J Pediatr Neurosci 7: 120.
Graus F et al. 2016. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15: 391ā404.
Granata T, Matricardi S, Ragona F, Freri E, Zibordi F, Andreetta F, Binelli S, Nardocci N, 2018. Pediatric NMDAR encephalitis: a single center observation study with a closer look at movement disorders. Eur J Paediatr Neurol 22: 301ā307.
Shrivastava SR, Shrivastava PS, Ramasamy J, 2015. Measles in India: challenges and recent developments. Infect Ecol Epidemiol 5: 27784.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 172 | 172 | 8 |
Full Text Views | 1839 | 217 | 2 |
PDF Downloads | 601 | 77 | 0 |
Subacute sclerosing panencephalitis (SSPE) is still a common disease in India which is characterized by a progressive mental decline, myoclonus, periodic encephalographic abnormalities, and raised anti-measles antibody titter in the cerebrospinal fluid. Acute fulminant SSPE is characterized by a rapid course of disease culminating in death, within 6 months. We report of a 10-year-old boy, who came with a 14-day history of continuous involuntary jerky movements of the left half of the body, including the head. There was a highly increased anti-measles IgG antibody titer, both in the cerebrospinal fluid and serum. We conclude that acute rapidly progressive SSPE can present as acute encephalitis syndrome.
Disclosure: The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and specific efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Authorsā addresses: Ravindra Kumar Garg and Hardeep Singh Malhotra, Department of Neurology, King Georgeās Medical University, Lucknow, India, E-mails: garg50@yahoo.com and drhsmalhotra@gmail.com. Neeraj Kumar, Imran Rizvi, Ravi Shekhar Jaipuriar, Praveen Kumar Sharma, and Ravi Uniyal, Department of Neurology, King Georgeās Medical University, Lucknow, India, E-mails: drneeraj2903@gmail.com, imranrizvi09@gmail.com, jaipuriarshekhar@gmail.com, pspgimer@gmail.com, and ravi.sun.uniyal@gmail.com. Amita Jain and Danish Nasar Khan, Department of Microbiology, King Georgeās Medical University, Lucknow, India, E-mails: amita602002@yahoo.com and microbiology@kgmcindia.edu.
World Health Organization, 2018. Immunization, Vaccines and Biologicals-Measles. WHO. Available at: http://www.who.int/immunization/diseases/measles/en/Downloaded. Accessed August 17, 2018.
Gurnani V, Haldar P, Aggarwal MK, Das MK, Chauhan A, Murray J, Arora NK, Jhalani M, Sudan P, 2018. Improving vaccination coverage in India: lessons from Intensified Mission Indradhanush, a cross-sectoral systems strengthening strategy. BMJ 363: k4782.
National Operational Guidelines, 2017. Measles-Rubella Vaccine Operational Guidelines, 2nd edition. New Delhi, India: Ministry of Health and Family Welfare, Government of India. Available at: https://mohfw.gov.in/sites/default/files/Measles%20rubella%20vaccine%20operational%20guidelines.pdf. Accessed February 14, 2019.
Fisher DL, Defres S, Solomon T, 2015. Measles-induced encephalitis. QJM 108: 177ā182.
Buchanan R, Bonthius DJ, 2012. Measles virus and associated central nervous system sequelae. Semin Pediatr Neurol 19: 107ā114.
Baldolli A, DargĆØre S, Cardineau E, Vabret A, Dina J, de La BlanchardiĆØre A, Verdon R, 2016. Measles inclusion-body encephalitis (MIBE) in a immunocompromised patient. J ClinVirol 81: 43ā46.
Griffin DE, 2014. Measles virus and the nervous system. Handb Clin Neurol 123: 577ā590.
Bien CG, Elger CE, 2008. Epilepsia partialis continua: semiology and differential diagnoses. Epileptic Disord 10: 3ā7.
Pandian JD, Thomas SV, Santoshkumar B, Radhakrishnan K, Sarma PS, Joseph S, Kesavadas C, 2002. Epilepsia partialis continuaāa clinical and electroencephalography study. Seizure 11: 437ā441.
MameniÅ”kienÄ R, Wolf P, 2017. Epilepsia partialis continua: a review. Seizure 44: 74ā80.
Takahashi Y et al. 2003. Kondo N Autoantibodies to NMDA receptor in patients with chronic forms of epilepsia partialis continua. Neurology 61: 891ā896.
Malhotra HS, Garg RK, Naphade P, 2012. Cluster of partial motor seizures heralding the onset of hemimyoclonic subacute sclerosing panencephalitis. Mov Disord 27: 958ā959.
Garg RK, Malhotra HS, Rizvi I, Kumar N, Jain A, 2017. An unusual case of acute encephalitic syndrome: is it acute measles encephalitis or subacute sclerosing panencephalitis? Neurol India 65: 1333ā1344.
Komur M, Arslankoylu AE, Okuyaz C, Kuyucu N, 2012. Atypical clinical course subacute sclerosing panencephalitis presenting as acute encephalitis. J Pediatr Neurosci 7: 120.
Graus F et al. 2016. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15: 391ā404.
Granata T, Matricardi S, Ragona F, Freri E, Zibordi F, Andreetta F, Binelli S, Nardocci N, 2018. Pediatric NMDAR encephalitis: a single center observation study with a closer look at movement disorders. Eur J Paediatr Neurol 22: 301ā307.
Shrivastava SR, Shrivastava PS, Ramasamy J, 2015. Measles in India: challenges and recent developments. Infect Ecol Epidemiol 5: 27784.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 172 | 172 | 8 |
Full Text Views | 1839 | 217 | 2 |
PDF Downloads | 601 | 77 | 0 |